リラグルチド薬の世界市場2020-2026:ビクトーザ、サクセンダ

QYResearchが発行した調査報告書(QYR20AP01340)
◆英語タイトル:Global Liraglutide Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP01340
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月
◆ページ数:115
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥563,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥845,250見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,127,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、リラグルチド薬の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、リラグルチド薬のグローバル市場動向、メーカー別競争状況、種類別市場規模(ビクトーザ、サクセンダ)、用途別市場規模(2型糖尿病、肥満)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・リラグルチド薬の種類別市場2015-2026:ビクトーザ、サクセンダ
・リラグルチド薬の用途別市場2015-2026:2型糖尿病、肥満
・リラグルチド薬の北米市場分析
・リラグルチド薬のアジア市場分析
・リラグルチド薬の中南米市場分析
・リラグルチド薬の中東・アフリカ市場分析
・関連企業情報:Novo Nordisk、Mylan
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion.In 2019, the global Liraglutide Drugs market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Liraglutide Drugs.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Liraglutide Drugs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Liraglutide Drugs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Liraglutide Drugs market. Readers of the report can become informed about current and future trends of the global Liraglutide Drugs market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Liraglutide Drugs markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Liraglutide Drugs market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Liraglutide Drugs market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Liraglutide Drugs market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Liraglutide Drugs market is segmented into
Victoza
Saxenda

Market Segment by Application, the Liraglutide Drugs market is segmented into
Type 2 Diabetes
Obesity

This report includes the following manufacturers; we can also add the other companies as you want.
Novo Nordisk
Mylan

The study objectives are:
To analyze and research the global Liraglutide Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Liraglutide Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Liraglutide Drugs are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Liraglutide Drugs Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Liraglutide Drugs Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Victoza
1.3.3 Saxenda
1.4 Market Segment by Application
1.4.1 Global Liraglutide Drugs Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Type 2 Diabetes
1.4.3 Obesity
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Liraglutide Drugs Revenue (2015-2026)
2.1.1 Global Liraglutide Drugs Revenue (2015-2026)
2.1.2 Global Liraglutide Drugs Sales (2015-2026)
2.2 Liraglutide Drugs Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Liraglutide Drugs Sales by Regions (2015-2020)
2.2.2 Global Liraglutide Drugs Revenue by Regions (2015-2020)
2.3 Global Top Liraglutide Drugs Regions (Countries) Ranking by Market Size
2.4 Liraglutide Drugs Industry Trends
2.4.1 Liraglutide Drugs Market Top Trends
2.4.2 Market Drivers
2.4.3 Liraglutide Drugs Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Liraglutide Drugs Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Liraglutide Drugs Manufacturers by Sales (2015-2020)
3.1.1 Global Liraglutide Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Liraglutide Drugs Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Liraglutide Drugs Sales in 2019
3.2 Global Top Manufacturers Liraglutide Drugs by Revenue
3.2.1 Global Liraglutide Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Liraglutide Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Liraglutide Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liraglutide Drugs as of 2019)
3.4 Global Liraglutide Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Liraglutide Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Liraglutide Drugs Market
3.7 Key Manufacturers Liraglutide Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Liraglutide Drugs Historic Market Review by Type (2015-2020)
4.1.2 Global Liraglutide Drugs Sales Market Share by Type (2015-2020)
4.1.3 Global Liraglutide Drugs Revenue Market Share by Type (2015-2020)
4.1.4 Liraglutide Drugs Price by Type (2015-2020)
4.1 Global Liraglutide Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Liraglutide Drugs Sales Forecast by Type (2021-2026)
4.2.3 Global Liraglutide Drugs Revenue Forecast by Type (2021-2026)
4.2.4 Liraglutide Drugs Price Forecast by Type (2021-2026)

5 Global Liraglutide Drugs Market Size by Application
5.1 Global Liraglutide Drugs Historic Market Review by Application (2015-2020)
5.1.2 Global Liraglutide Drugs Sales Market Share by Application (2015-2020)
5.1.3 Global Liraglutide Drugs Revenue Market Share by Application (2015-2020)
5.1.4 Liraglutide Drugs Price by Application (2015-2020)
5.2 Global Liraglutide Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Liraglutide Drugs Sales Forecast by Application (2021-2026)
5.2.3 Global Liraglutide Drugs Revenue Forecast by Application (2021-2026)
5.2.4 Liraglutide Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Liraglutide Drugs Breakdown Data by Company
6.2 North America Liraglutide Drugs Breakdown Data by Type
6.3 North America Liraglutide Drugs Breakdown Data by Application
6.4 North America Liraglutide Drugs Breakdown Data by Countries
6.4.1 North America Liraglutide Drugs Sales by Countries
6.4.2 North America Liraglutide Drugs Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Liraglutide Drugs Breakdown Data by Company
7.2 Europe Liraglutide Drugs Breakdown Data by Type
7.3 Europe Liraglutide Drugs Breakdown Data by Application
7.4 Europe Liraglutide Drugs Breakdown Data by Countries
7.4.1 Europe Liraglutide Drugs Sales by Countries
7.4.2 Europe Liraglutide Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Liraglutide Drugs Breakdown Data by Company
8.2 Asia Pacific Liraglutide Drugs Breakdown Data by Type
8.3 Asia Pacific Liraglutide Drugs Breakdown Data by Application
8.4 Asia Pacific Liraglutide Drugs Breakdown Data by Regions
8.4.1 Asia Pacific Liraglutide Drugs Sales by Regions
8.4.2 Asia Pacific Liraglutide Drugs Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Liraglutide Drugs Breakdown Data by Company
9.2 Latin America Liraglutide Drugs Breakdown Data by Type
9.3 Latin America Liraglutide Drugs Breakdown Data by Application
9.4 Latin America Liraglutide Drugs Breakdown Data by Countries
9.4.1 Latin America Liraglutide Drugs Sales by Countries
9.4.2 Latin America Liraglutide Drugs Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Liraglutide Drugs Breakdown Data by Type
10.2 Middle East and Africa Liraglutide Drugs Breakdown Data by Application
10.3 Middle East and Africa Liraglutide Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Liraglutide Drugs Sales by Countries
10.3.2 Middle East and Africa Liraglutide Drugs Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Novo Nordisk Liraglutide Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Liraglutide Drugs Products and Services
11.1.5 Novo Nordisk SWOT Analysis
11.1.6 Novo Nordisk Recent Developments
11.2 Mylan
11.2.1 Mylan Corporation Information
11.2.2 Mylan Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Mylan Liraglutide Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Mylan Liraglutide Drugs Products and Services
11.2.5 Mylan SWOT Analysis
11.2.6 Mylan Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Liraglutide Drugs Sales Channels
12.2.2 Liraglutide Drugs Distributors
12.3 Liraglutide Drugs Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Liraglutide Drugs Sales Forecast (2021-2026)
13.1.1 Global Liraglutide Drugs Sales Forecast by Regions (2021-2026)
13.1.2 Global Liraglutide Drugs Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Liraglutide Drugs Sales Forecast (2021-2026)
13.2.2 North America Liraglutide Drugs Revenue Forecast (2021-2026)
13.2.3 North America Liraglutide Drugs Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Liraglutide Drugs Sales Forecast (2021-2026)
13.3.2 Europe Liraglutide Drugs Revenue Forecast (2021-2026)
13.3.3 Europe Liraglutide Drugs Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Liraglutide Drugs Sales Forecast (2021-2026)
13.4.2 Asia Pacific Liraglutide Drugs Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Liraglutide Drugs Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Liraglutide Drugs Sales Forecast (2021-2026)
13.5.2 Latin America Liraglutide Drugs Revenue Forecast (2021-2026)
13.5.3 Latin America Liraglutide Drugs Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Liraglutide Drugs Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Liraglutide Drugs Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Liraglutide Drugs Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Liraglutide Drugs Key Market Segments
Table 2. Ranking of Global Top Liraglutide Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Liraglutide Drugs Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of Victoza
Table 5. Major Manufacturers of Saxenda
Table 6. Global Liraglutide Drugs Market Share by Application 2019-2025 (K Units)
Table 7. Global Liraglutide Drugs Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 8. Global Liraglutide Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global Liraglutide Drugs Sales Market Share by Regions 2015-2020
Table 10. Global Liraglutide Drugs Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Liraglutide Drugs Revenue Market Share by Regions 2015-2020
Table 12. Top Liraglutide Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Liraglutide Drugs Key Drivers: Impact Analysis (2021-2026)
Table 15. Liraglutide Drugs Key Challenges
Table 16. Main Points Interviewed from Key Liraglutide Drugs Players: Views for Future
Table 17. Global Liraglutide Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Liraglutide Drugs Sales Share by Manufacturers (2015-2020)
Table 19. Liraglutide Drugs Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Liraglutide Drugs Revenue Share by Manufacturers (2015-2020)
Table 21. Global Liraglutide Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liraglutide Drugs as of 2019)
Table 23. Key Manufacturers Liraglutide Drugs Average Selling Price (ASP) (2015-2020) (USD/Unit)
Table 24. Key Manufacturers Liraglutide Drugs Plants/Factories Distribution
Table 25. Key Manufacturers Liraglutide Drugs Area Served
Table 26. Date of Key Manufacturers Enter into Liraglutide Drugs Market
Table 27. Key Manufacturers Liraglutide Drugs Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Victoza Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 30. Global Saxenda Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 31. Global Liraglutide Drugs Sales (K Units) by Type (2015-2020)
Table 32. Global Liraglutide Drugs Sales Share by Type (2015-2020)
Table 33. Global Liraglutide Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Liraglutide Drugs Price (K Units) by Type (2015-2020)
Table 35. Global Liraglutide Drugs Sales (K Units) by Type (2021-2026)
Table 36. Global Liraglutide Drugs Sales Share by Type (2021-2026)
Table 37. Global Liraglutide Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Liraglutide Drugs Revenue Share by Type (2021-2026)
Table 39. Global Liraglutide Drugs Price (K Units) by Type (2021-2026)
Table 40. Global Liraglutide Drugs Sales (K Units) by Application (2015-2020)
Table 41. Global Liraglutide Drugs Sales Share by Application (2015-2020)
Table 42. Global Liraglutide Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Liraglutide Drugs Price by Application 2015-2020 (USD/Unit)
Table 44. Global Liraglutide Drugs Sales by Application (2015-2020) (K Units)
Table 45. Global Liraglutide Drugs Sales Share by Application (2015-2020)
Table 46. Global Liraglutide Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Liraglutide Drugs Revenue Share by Application (2021-2026)
Table 48. Global Liraglutide Drugs Price (K Units) by Application (2021-2026)
Table 49. North America Liraglutide Drugs Sales by Company (2015-2020) (K Units)
Table 50. North America Liraglutide Drugs Sales Market Share by Company (2015-2020)
Table 51. North America Liraglutide Drugs Sales by Type (2015-2020) (K Units)
Table 52. North America Liraglutide Drugs Sales Market Share by Type (2015-2020)
Table 53. North America Liraglutide Drugs Sales by Application (2015-2020) (K Units)
Table 54. North America Liraglutide Drugs Sales Market Share by Application (2015-2020)
Table 55. North America Liraglutide Drugs Sales by Countries (2015-2020) (K Units)
Table 56. North America Liraglutide Drugs Sales Market Share by Countries (2015-2020)
Table 57. North America Liraglutide Drugs Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Liraglutide Drugs Revenue Market Share by Countries (2015-2020)
Table 59. Europe Liraglutide Drugs Sales by Company (2015-2020) (K Units)
Table 60. Europe Liraglutide Drugs Sales Market Share by Company (2015-2020)
Table 61. Europe Liraglutide Drugs Sales by Type (2015-2020) (K Units)
Table 62. Europe Liraglutide Drugs Sales Market Share by Type (2015-2020)
Table 63. Europe Liraglutide Drugs Sales by Application (2015-2020) (K Units)
Table 64. Europe Liraglutide Drugs Sales Market Share by Application (2015-2020)
Table 65. Europe Liraglutide Drugs Sales by Countries (2015-2020) (K Units)
Table 66. Europe Liraglutide Drugs Sales Market Share by Countries (2015-2020)
Table 67. Europe Liraglutide Drugs Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Liraglutide Drugs Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Liraglutide Drugs Sales by Regions (2015-2020) (K Units)
Table 70. Asia Pacific Liraglutide Drugs Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Liraglutide Drugs Sales by Type (2015-2020) (K Units)
Table 72. Asia Pacific Liraglutide Drugs Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Liraglutide Drugs Sales by Application (2015-2020) (K Units)
Table 74. Asia Pacific Liraglutide Drugs Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Liraglutide Drugs Sales by Countries (2015-2020) (K Units)
Table 76. Asia Pacific Liraglutide Drugs Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Liraglutide Drugs Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Liraglutide Drugs Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Liraglutide Drugs Sales by Company (2015-2020) (K Units)
Table 80. Latin America Liraglutide Drugs Sales Market Share by Company (2015-2020)
Table 81. Latin America Liraglutide Drugs Sales by Type (2015-2020) (K Units)
Table 82. Latin America Liraglutide Drugs Sales Market Share by Type (2015-2020)
Table 83. Latin America Liraglutide Drugs Sales by Application (2015-2020) (K Units)
Table 84. Latin America Liraglutide Drugs Sales Market Share by Application (2015-2020)
Table 85. Latin America Liraglutide Drugs Sales by Countries (2015-2020) (K Units)
Table 86. Latin America Liraglutide Drugs Sales Market Share by Countries (2015-2020)
Table 87. Latin America Liraglutide Drugs Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Liraglutide Drugs Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Liraglutide Drugs Sales by Type (2015-2020) (K Units)
Table 90. Middle East and Africa Liraglutide Drugs Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Liraglutide Drugs Sales by Application (2015-2020) (K Units)
Table 92. Middle East and Africa Liraglutide Drugs Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Liraglutide Drugs Sales by Countries (2015-2020) (K Units)
Table 94. Middle East and Africa Liraglutide Drugs Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Liraglutide Drugs Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Liraglutide Drugs Revenue Market Share by Countries (2015-2020)
Table 97. Novo Nordisk Company Details
Table 98. Novo Nordisk Description and Business Overview
Table 99. Novo Nordisk Liraglutide Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Novo Nordisk Liraglutide Drugs Sales Growth Rate (2015-2020)
Table 101. Novo Nordisk Liraglutide Drugs Sales Market Share in Global Market
Table 102. Novo Nordisk Recent Development
Table 103. Mylan Company Details
Table 104. Mylan Description and Business Overview
Table 105. Mylan Liraglutide Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Mylan Liraglutide Drugs Sales Growth Rate (2015-2020)
Table 107. Mylan Liraglutide Drugs Sales Market Share in Global Market
Table 108. Mylan Recent Development
Table 109. Liraglutide Drugs Distributors List
Table 110. Liraglutide Drugs Customers List
Table 111. Global Liraglutide Drugs Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 112. Global Liraglutide Drugs Sales Forecast by Type 2021-2026 (K Units)
Table 113. Global Liraglutide Drugs Sales Forecast by Application 2021-2026 (K Units)
Table 114. Global Liraglutide Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 115. Global Liraglutide Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 116. North America Liraglutide Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 117. North America Liraglutide Drugs Revenue Forecast by Countries 2021-2026
Table 118. Europe Liraglutide Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 119. Europe Liraglutide Drugs Revenue Market Share Forecast by Countries 2021-2026
Table 120. Asia Pacific Liraglutide Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 121. Asia Pacific Liraglutide Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 122. Latin America Liraglutide Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 123. Latin America Liraglutide Drugs Revenue Forecast by Countries 2021-2026 (Million US$)
Table 124. Middle East and Africa Liraglutide Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 125. Middle East and Africa Liraglutide Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Liraglutide Drugs Product Picture
Figure 2. Global Liraglutide Drugs Sales Market Shar by Type 2015-2026
Figure 3. Victoza Figures
Figure 4. Saxenda Figures
Figure 5. Global Liraglutide Drugs Sales Market Share by Application in 2019 & 2026
Figure 6. Type 2 Diabetes Use Case
Figure 7. Obesity Use Case
Figure 8. Liraglutide Drugs Report Years Considered
Figure 9. Global Liraglutide Drugs Market Size 2015-2026 (Million US$)
Figure 10. Global Liraglutide Drugs Sales 2015-2020 (K Units)
Figure 11. Global Liraglutide Drugs Market Size Market Share by Regions 2015-2020
Figure 12. Global Liraglutide Drugs Sales Market Share by Regions in 2019
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Liraglutide Drugs Sales Share by Manufacturers in 2019
Figure 15. The 5 and 10 Largest Manufacturers in the World: Market Share by Liraglutide Drugs Sales in 2019
Figure 16. Liraglutide Drugs Value Share by Manufacturers in 2019
Figure 17. Liraglutide Drugs Revenue Share by Manufacturers In 2019
Figure 18. Liraglutide Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Liraglutide Drugs Revenue Share by Type (2015-2020)
Figure 20. Global Liraglutide Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 21. Global Liraglutide Drugs Market Share by Price Range (2015-2020)
Figure 22. Global Liraglutide Drugs Revenue Share by Application (2015-2020)
Figure 23. Global Liraglutide Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 24. North America Liraglutide Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 25. U.S. Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 27. Europe Liraglutide Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. Germany Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 29. France Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 30. U.K. Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 31. Italy Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 32. Russia Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 33. Asia Pacific Liraglutide Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 34. China Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. Japan Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. South Korea Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. India Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. Australia Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. Taiwan Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 40. Indonesia Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. Thailand Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 42. Malaysia Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Philippines Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Vietnam Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. Latin America Liraglutide Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 46. Mexico Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. Brazil Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. Argentina Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. Middle East and Africa Liraglutide Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 50. Turkey Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Saudi Arabia Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.A.E Liraglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Liraglutide Drugs Value Chain
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. North America Liraglutide Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 59. North America Liraglutide Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 60. Europe Liraglutide Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 61. Europe Liraglutide Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 62. Asia Pacific Liraglutide Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 63. Asia Pacific Liraglutide Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 64. Latin America Liraglutide Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 65. Latin America Liraglutide Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 66. Middle East and Africa Liraglutide Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 67. Middle East and Africa Liraglutide Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed


【掲載企業】

Novo Nordisk、Mylan

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ リラグルチド薬の世界市場2020-2026:ビクトーザ、サクセンダ(Global Liraglutide Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。